Clinical Trials · NCT07294950

Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination

Phase
Phase 3
Recruitment status
Recruiting
Sponsor
Mount Sinai Hospital, Canada
Enrollment
98
Start date
Feb 2026
Locations
1 site, Canada
Primary endpoint
Differences in changes in body weight between each study group
View Semaglutide compound reference